(Q40837155)

24 September 2017

Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections (English)

1 reference

24 September 2017

J. L. Abbruzzese

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220603

31 August 2023

L. E. Rocco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220603

31 August 2023

O. L. Laskin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220603

31 August 2023

K. M. Skubitz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220603

31 August 2023

M. D. McGaughey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220603

31 August 2023

J. J. Lipsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220603

31 August 2023

language of work or name

English

0 references

publication date

1 April 1983

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:000293438391029X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

https://api.elsevier.com/content/article/PII:000293438391029X?httpAccept=text/plain

31 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

American Journal of Medicine

31 August 2023

published in

1 reference

24 September 2017

74

1 reference

24 September 2017

4

1 reference

24 September 2017

694-699

1 reference

Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation

24 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds

31 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

In vitro activity of LY127935.

31 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers

31 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

31 August 2023

Culture of the urine

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections

31 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Clinical evaluation of tobramycin in urinary tract infections

31 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Comparison of tobramycin and gentamicin in the treatment of complicated urinary tract infections

31 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections

31 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

The pathogenesis of experimental enterococcal pyelonephritis in mice

31 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

31 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.

31 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Moxalactam therapy for a wide spectrum of bacterial infections in adults

31 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

Clinical evaluation of moxalactam

31 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91029-X

31 August 2023

Identifiers

1 reference

24 September 2017

1 reference